4526 — Riken Vitamin Co Balance Sheet
0.000.00%
- ¥79bn
- ¥67bn
- ¥96bn
- 73
- 72
- 88
- 92
Annual balance sheet for Riken Vitamin Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 19,230 | 17,302 | 19,155 | 23,384 | 22,298 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 18,311 | 18,715 | 20,116 | 23,114 | 21,808 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 53,326 | 52,790 | 58,126 | 66,521 | 65,699 |
Net Property, Plant And Equipment | 27,861 | 25,428 | 23,637 | 23,382 | 25,525 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 106,535 | 102,660 | 105,223 | 118,776 | 112,999 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 52,812 | 18,221 | 18,924 | 31,117 | 21,129 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 60,378 | 36,140 | 33,878 | 42,163 | 33,837 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 46,157 | 66,520 | 71,345 | 76,613 | 79,162 |
Total Liabilities & Shareholders' Equity | 106,535 | 102,660 | 105,223 | 118,776 | 112,999 |
Total Common Shares Outstanding |